2024 Q1 Form 10-Q Financial Statement

#000147793224001197 Filed on March 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q1
Revenue $11.84M $10.78M
YoY Change 9.89% 21.41%
Cost Of Revenue $8.469M $8.335M
YoY Change 1.61% 21.62%
Gross Profit $3.375M $2.443M
YoY Change 38.16% 20.7%
Gross Profit Margin 28.5% 22.67%
Selling, General & Admin $3.096M $2.772M
YoY Change 11.69% 73.26%
% of Gross Profit 91.73% 113.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $121.4K $9.897K
YoY Change 1127.04% -89.77%
% of Gross Profit 3.6% 0.41%
Operating Expenses $3.096M $2.772M
YoY Change 11.69% 71.1%
Operating Profit $279.2K -$329.0K
YoY Change -184.87% -181.43%
Interest Expense $57.48K $998.00
YoY Change 5659.52%
% of Operating Profit 20.59%
Other Income/Expense, Net $57.48K $31.12K
YoY Change 84.71% -63.44%
Pretax Income $336.7K -$297.8K
YoY Change -213.05% -160.9%
Income Tax $262.2K $145.7K
% Of Pretax Income 77.87%
Net Earnings $74.51K -$443.5K
YoY Change -116.8% -207.22%
Net Earnings / Revenue 0.63% -4.12%
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 36.25M shares 35.57M shares
Diluted Shares Outstanding 38.78M shares 33.31M shares

Balance Sheet

Concept 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.29M $15.42M
YoY Change 12.12% 1.19%
Cash & Equivalents $17.29M $15.42M
Short-Term Investments
Other Short-Term Assets $196.8K $332.3K
YoY Change -40.77% 98.73%
Inventory $2.377M $1.613M
Prepaid Expenses $143.0K $274.7K
Receivables $4.328M $3.490M
Other Receivables $0.00 $0.00
Total Short-Term Assets $24.19M $21.21M
YoY Change 14.05% 14.65%
LONG-TERM ASSETS
Property, Plant & Equipment $375.8K $78.48K
YoY Change 378.87% 157.16%
Goodwill $10.38M $10.38M
YoY Change 0.0% -3.15%
Intangibles $2.145M $2.569M
YoY Change -16.48%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $12.90M $13.17M
YoY Change -2.02% -3.39%
TOTAL ASSETS
Total Short-Term Assets $24.19M $21.21M
Total Long-Term Assets $12.90M $13.17M
Total Assets $37.10M $34.38M
YoY Change 7.89% 7.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.866M $2.098M
YoY Change 36.58% 73.74%
Accrued Expenses $745.7K $602.5K
YoY Change 23.76% -12.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.693M $3.829M
YoY Change 22.57% -13.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $257.1K $37.73K
YoY Change 581.37% -73.84%
Total Long-Term Liabilities $257.1K $37.73K
YoY Change 581.31% -73.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.693M $3.829M
Total Long-Term Liabilities $257.1K $37.73K
Total Liabilities $4.950M $3.867M
YoY Change 28.03% -15.15%
SHAREHOLDERS EQUITY
Retained Earnings -$25.77M -$25.12M
YoY Change 2.61% 4.33%
Common Stock $366.00 $361.00
YoY Change 1.39% 28.93%
Preferred Stock
YoY Change
Treasury Stock (at cost) $32.32K
YoY Change
Treasury Stock Shares 666.3K shares
Shareholders Equity $32.15M $30.52M
YoY Change
Total Liabilities & Shareholders Equity $37.10M $34.38M
YoY Change 7.89% 7.0%

Cashflow Statement

Concept 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $74.51K -$443.5K
YoY Change -116.8% -207.22%
Depreciation, Depletion And Amortization $121.4K $9.897K
YoY Change 1127.04% -89.77%
Cash From Operating Activities $8.180K $401.7K
YoY Change -97.96% -78.19%
INVESTING ACTIVITIES
Capital Expenditures $1.510K $60.92K
YoY Change -97.52% -213.09%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$1.510K -$60.92K
YoY Change -97.52% -98.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 8.180K $401.7K
Cash From Investing Activities -1.510K -$60.92K
Cash From Financing Activities $0.00
Net Change In Cash 6.670K $474.2K
YoY Change -98.59% -130.49%
FREE CASH FLOW
Cash From Operating Activities $8.180K $401.7K
Capital Expenditures $1.510K $60.92K
Free Cash Flow $6.670K $340.7K
YoY Change -98.04% -82.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4693335 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4479423 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
257077 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
257077 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
366 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
124732 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4031349 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3551383 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
2376836 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1714525 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
24194465 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
22852676 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2865859 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2847653 usd
CY2024Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
664444 usd
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
476485 usd
CY2024Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
19748 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
18819 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
81086 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
59089 usd
CY2024Q1 us-gaap Customer Deposits Current
CustomerDepositsCurrent
291238 usd
CY2023Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
348620 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
123 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
362 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57023788 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-73159 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25847597 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
142992 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
103271 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40139 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2245341 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56643 usd
CY2024Q1 us-gaap Goodwill
Goodwill
10381710 usd
CY2023Q4 us-gaap Goodwill
Goodwill
10381710 usd
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
12902688 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
12730141 usd
CY2024Q1 us-gaap Assets
Assets
37097153 usd
CY2023Q4 us-gaap Assets
Assets
35582817 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
130560 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
123 usd
CY2024Q1 gmgi Contingent Liability Current
ContingentLiabilityCurrent
636650 usd
CY2023Q4 gmgi Contingent Liability Current
ContingentLiabilityCurrent
607607 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17100280 usd
CY2024Q1 gmgi Related Party Transaction Accounts Receivable
RelatedPartyTransactionAccountsReceivable
296472 usd
CY2023Q4 gmgi Related Party Transaction Accounts Receivable
RelatedPartyTransactionAccountsReceivable
331246 usd
CY2024Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
53838 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
51971 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46447 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2145137 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
335702 usd
CY2024Q1 gmgi Related Party Transaction Accounts Payable
RelatedPartyTransactionAccountsPayable
3627 usd
CY2023Q4 gmgi Related Party Transaction Accounts Payable
RelatedPartyTransactionAccountsPayable
12921 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
108106 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
2771989 usd
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001437925
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36615932 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36162932 shares
CY2023Q1 gmgi Preferred Shares
PreferredShares
0 shares
CY2023Q1 gmgi Restricted Stock Units
RestrictedStockUnits
0 shares
CY2023Q1 gmgi Warrants Options
WarrantsOptions
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 gmgi Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod
0 shares
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-01-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-41326
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Golden Matrix Group, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-1814729
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3651 Lindell Road
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Ste D131
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89103
CY2024Q1 dei City Area Code
CityAreaCode
702
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
318-7548
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.00001 Par Value Per Share
CY2024Q1 dei Trading Symbol
TradingSymbol
GMGI
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36615932 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17292978 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 usd
CY2024Q1 us-gaap Liabilities
Liabilities
4950412 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4479423 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36615932 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36162932 shares
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57794735 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25773092 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
32146741 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
31103394 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37097153 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35582817 usd
CY2024Q1 gmgi Revenues Excluding Related Party
RevenuesExcludingRelatedParty
11778656 usd
CY2023Q1 gmgi Revenues Excluding Related Party
RevenuesExcludingRelatedParty
10591036 usd
CY2024Q1 gmgi Revenue From Related Party
RevenueFromRelatedParty
65226 usd
CY2023Q1 gmgi Revenue From Related Party
RevenueFromRelatedParty
186643 usd
CY2024Q1 us-gaap Revenues
Revenues
11843882 usd
CY2023Q1 us-gaap Revenues
Revenues
10777679 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8468622 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8334645 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
3375260 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
2443034 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2336792 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2037295 usd
CY2024Q1 gmgi Related Party Transaction Selling General And Administrative Expense From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpenseFromTransactionsWithRelatedParty
759264 usd
CY2023Q1 gmgi Related Party Transaction Selling General And Administrative Expense From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpenseFromTransactionsWithRelatedParty
734694 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
3096056 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
279204 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-328955 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
600 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
998 usd
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
39264 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
11905 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
18817 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
20213 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
57481 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31120 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
336685 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-297835 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
262180 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
145686 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
74505 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-443521 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36276139 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33311667 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38779778 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33311667 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
74505 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-443521 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
197891 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
152259 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
272396 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-291262 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
29796481 usd
CY2023Q1 gmgi Shares Issued As Consideration To Acquire Rkings Amount
SharesIssuedAsConsiderationToAcquireRkingsAmount
0 usd
CY2023Q1 gmgi Stock Issued During Period Value Cashless Stock Options Exercised
StockIssuedDuringPeriodValueCashlessStockOptionsExercised
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
263389 usd
CY2023Q1 gmgi Shares Issued For Vested Restricted Stock Units Amount
SharesIssuedForVestedRestrictedStockUnitsAmount
0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
818395 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
152259 usd
CY2023Q1 gmgi Adjustment To Reduce Nci Amount Recorded For Rkings Acquisition
AdjustmentToReduceNciAmountRecordedForRkingsAcquisition
-70614 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-443521 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
30516389 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
31103394 usd
CY2024Q1 gmgi Shares Issued For Vested Restricted Stock Units Amount
SharesIssuedForVestedRestrictedStockUnitsAmount
0 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
770951 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
197891 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
74505 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
32146741 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
74505 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-443521 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
770951 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
818395 usd
CY2024Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
263389 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-29043 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-42642 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-111546 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-106666 usd
CY2024Q1 us-gaap Depreciation
Depreciation
9894 usd
CY2023Q1 us-gaap Depreciation
Depreciation
9897 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
766129 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
820054 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-34774 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-58358 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
38971 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-6601 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
571196 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
378170 usd
CY2024Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
280141 usd
CY2023Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-23993 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
251584 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
626252 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-9868 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
17767 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
162611 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
145686 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
16927 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-55912 usd
CY2024Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-67423 usd
CY2023Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
3642 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
280068 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-23978 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8175 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
401653 usd
CY2024Q1 gmgi Cash Paid For Leasehold Improvement
CashPaidForLeaseholdImprovement
0 usd
CY2023Q1 gmgi Cash Paid For Leasehold Improvement
CashPaidForLeaseholdImprovement
-6202 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1511 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1933 usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
52788 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1511 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60923 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
186034 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133494 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
192698 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
474224 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17100280 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14949673 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17292978 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15423897 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
600 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
998 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
99569 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 gmgi Stock Issued During Period Value Stock Option Exercised
StockIssuedDuringPeriodValueStockOptionExercised
0 usd
CY2023Q1 gmgi Stock Issued During Period Value Stock Option Exercised
StockIssuedDuringPeriodValueStockOptionExercised
71 usd
CY2024Q1 gmgi Acquisition Of Shares Of Rkings
AcquisitionOfSharesOfRkings
0 usd
CY2023Q1 gmgi Acquisition Of Shares Of Rkings
AcquisitionOfSharesOfRkings
488060 usd
CY2024Q1 gmgi Accounts Payable Settled With Accounts Receivable
AccountsPayableSettledWithAccountsReceivable
300000 usd
CY2023Q1 gmgi Accounts Payable Settled With Accounts Receivable
AccountsPayableSettledWithAccountsReceivable
0 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include contingent liability, stock-based compensation, warrant valuation, accrued expenses and collectability of accounts receivable. The Company evaluates its estimates on an on-going basis and bases its estimates on historical experience and on various other assumptions the Company believes to be reasonable. Due to inherent uncertainties, actual results could differ from those estimates.</p>
CY2024Q1 us-gaap Other Inventory Supplies
OtherInventorySupplies
82167 usd
CY2023Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
90329 usd
CY2024Q1 gmgi Prepayment For The Gaming License Fee
PrepaymentForTheGamingLicenseFee
56194 usd
CY2023Q4 gmgi Prepayment For The Gaming License Fee
PrepaymentForTheGamingLicenseFee
8528 usd
CY2024Q1 gmgi Prepaid Payroll Expense
PrepaidPayrollExpense
4631 usd
CY2024Q1 gmgi Estimated Useful Lives Of Websites Intangible Assets
EstimatedUsefulLivesOfWebsitesIntangibleAssets
P3Y
CY2024Q1 us-gaap Development Costs
DevelopmentCosts
0 usd
CY2023Q1 us-gaap Development Costs
DevelopmentCosts
52788 usd
CY2023Q4 gmgi Prepaid Payroll Expense
PrepaidPayrollExpense
4414 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
74505 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-443521 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36276139 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33311667 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q1 gmgi Net Income Loss Available To Common Shareholders
NetIncomeLossAvailableToCommonShareholders
74505 usd
CY2023Q1 gmgi Net Income Loss Available To Common Shareholders
NetIncomeLossAvailableToCommonShareholders
-443521 usd
CY2024Q1 gmgi Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
36276139 shares
CY2023Q1 gmgi Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
33311667 shares
CY2024Q1 gmgi Preferred Shares
PreferredShares
1000000 shares
CY2024Q1 gmgi Warrants Options
WarrantsOptions
216139 shares
CY2024Q1 gmgi Restricted Stock Units
RestrictedStockUnits
1287500 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
38779778 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
33311667 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
197891 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
152259 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
18817 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
20213 usd
CY2024Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
300000 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
0 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
335702 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56643 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
81086 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
59089 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
257077 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2024Q1 us-gaap Minority Interest Ownership Percentage By Noncontrolling Owners
MinorityInterestOwnershipPercentageByNoncontrollingOwners
0.20 pure
CY2024Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2634386 usd
CY2024Q1 gmgi Finite Lived Intangible Asset Accumulated Amortization
FiniteLivedIntangibleAssetAccumulatedAmortization
980450 usd
CY2023Q4 gmgi Finite Lived Intangible Asset Accumulated Amortization
FiniteLivedIntangibleAssetAccumulatedAmortization
863758 usd
CY2024Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
2145137 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
2245341 usd
CY2024Q1 gmgi Related Party Transaction Accounts Payable
RelatedPartyTransactionAccountsPayable
3627 usd
CY2023Q4 gmgi Related Party Transaction Accounts Payable
RelatedPartyTransactionAccountsPayable
12921 usd
CY2024Q1 us-gaap Deferred Revenue
DeferredRevenue
130560 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
108106 usd
CY2024Q1 gmgi Progressive Contribution Fee
ProgressiveContributionFee
5000 usd
CY2024Q1 us-gaap Customer Deposits Current
CustomerDepositsCurrent
291238 usd
CY2023Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
348620 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36162932 shares
CY2023Q2 gmgi Restricted Shares Of Common Stock Vested
RestrictedSharesOfCommonStockVested
100000 shares
CY2023Q2 gmgi Share Price Of Stock
SharePriceOfStock
1.74
CY2023Q2 us-gaap Officers Compensation
OfficersCompensation
90230 usd
CY2024Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
61679 usd
CY2023Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
132525 usd
CY2022Q3 gmgi Net Restricted Units
NetRestrictedUnits
1575000 shares
CY2024Q1 gmgi Schedule Of Grant And Vesting Of Restricted Stock Units Table Textblock
ScheduleOfGrantAndVestingOfRestrictedStockUnitsTableTextblock
<table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Recipient</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Position with Company</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>of RSUs</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:21%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Anthony Brian Goodman</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">President, Chief Executive Officer (Principal Executive Officer), Secretary, Treasurer, and Chairman of the Board of Directors</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">750,000</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weiting ‘Cathy’ Feng </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Chief Operating Officer and Director of the Company</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">375,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Murray G. Smith </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Independent Director</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">150,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Aaron Richard Johnston</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Former Independent Director</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">150,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thomas E. McChesney</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Independent Director</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">150,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>1,575,000</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2024Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
1575000 shares
CY2024Q1 gmgi Schedule Of Performance Metrics Table Textblock
ScheduleOfPerformanceMetricsTableTextblock
<table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:24%;"></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="4" style="BORDER-BOTTOM: 1px solid;width:26%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Revenue Targets</strong></p></td><td colspan="5" style="BORDER-BOTTOM: 1px solid;width:26%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Adjusted EBITDA Targets</strong></p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:24%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Performance Period</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:11%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Target Goal</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:11%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>RSUs Vested</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:12%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Target Goal</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:11%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>RSUs Vested</strong></p></td><td></td><td></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:24%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Year ended October 31, 2022</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> $</p></td><td style="width:11%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 21,875,000</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">*</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> $</p></td><td style="width:12%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3,250,000</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">*</p></td><td></td><td></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:24%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Year ended October 31, 2023</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$39,638,342 (which equals FY 2022 revenue x 1.1)</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">*</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:12%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$3,879,197 (which equals FY 2022 Adjusted EBITDA x 1.1)</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">*</p></td><td></td><td></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:24%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Year ended October 31, 2024</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$48,591,457 (which equals FY 2023 revenue x 1.1)</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">*</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:12%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$2,637,004 (which equals FY 2023 Adjusted EBITDA x 1.1)</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">*</p></td><td></td><td></td></tr></tbody></table>
CY2022Q4 gmgi Restricted Shares Of Common Stock Vested
RestrictedSharesOfCommonStockVested
100000 shares
CY2024Q1 us-gaap Officers Compensation
OfficersCompensation
0 usd
CY2023Q1 us-gaap Officers Compensation
OfficersCompensation
253389 usd
CY2024Q1 gmgi Stock Outstanding Restricted Shares
StockOutstandingRestrictedShares
1625000 shares
CY2023Q4 gmgi Stock Outstanding Restricted Shares
StockOutstandingRestrictedShares
2082000 shares
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2000000 shares
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
14594 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
32322 usd
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
14594 shares
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
602628 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
476485 usd
CY2024Q1 gmgi Income Tax Expense Benefits
IncomeTaxExpenseBenefits
262180 usd
CY2024Q1 gmgi Income Taxe Paid
IncomeTaxePaid
-99569 usd
CY2024Q1 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
25348 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
664444 usd

Files In Submission

Name View Source Status
0001477932-24-001197-index-headers.html Edgar Link pending
0001477932-24-001197-index.html Edgar Link pending
0001477932-24-001197.txt Edgar Link pending
0001477932-24-001197-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gmgi-20240131.xsd Edgar Link pending
gmgi_10q.htm Edgar Link pending
gmgi_10qimg1.jpg Edgar Link pending
gmgi_ex311.htm Edgar Link pending
gmgi_ex312.htm Edgar Link pending
gmgi_ex321.htm Edgar Link pending
gmgi_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
gmgi-20240131_cal.xml Edgar Link unprocessable
gmgi-20240131_pre.xml Edgar Link unprocessable
gmgi_10q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gmgi-20240131_lab.xml Edgar Link unprocessable
gmgi-20240131_def.xml Edgar Link unprocessable